Establish the foundation
- Scientific, clinical and real-world evidence
- Regulatory requirements and obligations
- IP, process, quality and supply information
- Commercial and health-system priorities
THE HERMS PLATFORM
One connected intelligence platform for healthcare and life sciences worldwide. Explore 25 specialized applications linking scientific evidence, regulatory requirements, manufacturing, patient safety and commercial priorities.
HERMS
INTELLIGENCE SPINE
Evidence integrity · Model assurance · Human oversight
CONNECTED ARCHITECTURE
A common intelligence foundation is designed to preserve context as knowledge moves between specialist applications, teams and stages of the product lifecycle.
Connect sources, assumptions, requirements, dependencies, risks and decision history.
SIX INTELLIGENCE MOTORS
Six complementary functions define how the platform is designed to organise evidence, retain context and focus review.
Know where the evidence comes from.
Connect findings to their sources, dates and context so reviewers can assess their relevance.
Make complex knowledge usable.
Structure scientific evidence, regulatory obligations and process requirements for consistent analysis.
Understand what a change affects.
Map dependencies across development, manufacturing, regulation, safety and commercial decisions.
Compare options with context.
Expose trade-offs, assumptions, uncertainty and evidence gaps for qualified review.
Carry knowledge forward.
Preserve programme context as evidence and decisions move between stages and specialist applications.
Focus on what matters next.
Surface material gaps, emerging risks and decision gates that require timely human attention.
THE CONNECTED LIFECYCLE
A scientific finding can change a development strategy. A manufacturing change can affect clinical evidence, regulatory obligations, supply continuity and investment priorities.
Innovation discovery · product invention · precision delivery · clinical experiment design
Frame the opportunity, challenge its evidence and define the next learning milestone.
Gene therapy & genome editing · cell therapies & exosomes · IP & know-how · manufacturing technology transfer
Connect scientific translation to rights, process requirements and localisation readiness.
Regulatory strategy & submissions · lifecycle management · clinical value · pricing & HTA · tenders & agreements
Connect evidence obligations to approval pathways and defensible access decisions.
Bioprocess development & scale-up · manufacturing quality & validation · network optimisation · supply & cold chain · pharmacovigilance
Maintain continuity across process control, distribution, patient safety and lifecycle oversight.
Across every stage: research integrity, engagement ethics, data protection, medical and promotional communications, biotech capital allocation, evidence integrity and model assurance.
HUMAN ACCOUNTABILITY
AI-assisted analysis supports professional judgment within defined responsibilities and review processes.
Organise evidence, identify gaps, compare options and prepare recommendations with explicit assumptions and uncertainty.
Assess recommendations against applicable requirements, evidence thresholds and defined progression criteria.
Qualified reviewers challenge the evidence, approve the next action and retain accountability for decisions within their remit.
Source provenance, evidence integrity and model assurance underpin the platform approach. Supporting evidence, limitations and unresolved questions should remain clear enough to challenge.
ILLUSTRATIVE CONNECTED WORKFLOW
One transfer decision. Multiple connected disciplines.
Moving an innovation to a receiving facility requires scientific, technical, legal, quality, regulatory and economic questions to be assessed together.
Illustrative workflow showing the intended relationship between applications; project scope and demonstrated capabilities are established during assessment.
INNEXIS map IP, licences, materials, data rights, tacit knowledge, training and transfer obligations.
SYNTRIX and CONVORIQE connect process design, scale-up assumptions, facility fit and manufacturing footprint options.
AXION, RULEXIS and REGAXIS connect validation, comparability evidence and applicable regulatory pathways or lifecycle obligations.
CAPNEXIS and VERIQIS examine the investment case and challenge the evidence supporting each proposed commitment.
Responsible experts review readiness, unresolved gaps, ownership and conditions before approving progression.
Define the workflow, evidence, responsibilities and decision gates for a focused demonstration.
HERMS platform architecture and intended workflow design. Available functionality, deployment configuration and validation requirements are confirmed for each engagement.
ENGINEERING INTELLIGENCE. REVOLUTIONIZING LIFE SCIENCES.
We use essential cookies to run this website and, with your consent, analytics cookies to improve it. You can change your choice at any time. Cookie Policy · Privacy Policy
HERMS is the intelligence platform. Its applications are the decision engines. HERMS expert services support implementation and regulated execution of the HERMS intelligence ecosystem, from regulatory and market access to pharmacovigilance, compliance and quality.